Advertisement
Singapore markets close in 2 hours 51 minutes

  • Straits Times Index

    3,401.90
    -8.91 (-0.26%)
     

  • Nikkei

    40,858.78
    -53.59 (-0.13%)
     

  • Hang Seng

    17,480.67
    -318.94 (-1.79%)
     

  • FTSE 100

    8,203.93
    -37.33 (-0.45%)
     

  • Bitcoin USD

    55,270.32
    -2,453.68 (-4.25%)
     

  • CMC Crypto 200

    1,150.84
    -15.27 (-1.31%)
     

  • S&P 500

    5,567.19
    +30.17 (+0.54%)
     

  • Dow

    39,375.87
    +67.87 (+0.17%)
     

  • Nasdaq

    18,352.76
    +164.46 (+0.90%)
     

  • Gold

    2,390.80
    -6.90 (-0.29%)
     

  • Crude Oil

    82.75
    -0.41 (-0.49%)
     

  • 10-Yr Bond

    4.2720
    -0.0830 (-1.91%)
     

  • FTSE Bursa Malaysia

    1,611.02
    -5.73 (-0.35%)
     

  • Jakarta Composite Index

    7,248.00
    -5.37 (-0.07%)
     

  • PSE Index

    6,538.33
    +45.58 (+0.70%)
     

Guardant Health: Q1 Earnings Snapshot

Associated Press Finance
·1-min read

PALO ALTO, Calif. (AP) — PALO ALTO, Calif. (AP) — Guardant Health Inc. (GH) on Thursday reported a loss of $115 million in its first quarter.

On a per-share basis, the Palo Alto, California-based company said it had a loss of 94 cents. Losses, adjusted for non-recurring costs and stock option expense, came to 46 cents per share.

The results beat Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 72 cents per share.

The provider of oncology testing services posted revenue of $168.5 million in the period, which also beat Street forecasts. Eight analysts surveyed by Zacks expected $150.5 million.

ADVERTISEMENT

Guardant Health expects full-year revenue in the range of $675 million to $685 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on GH at https://www.zacks.com/ap/GH